dc.contributor.author | Disci, Rian | |
dc.contributor.author | Yasasever, Vildan | |
dc.contributor.author | Çamlıca, Hakan | |
dc.contributor.author | OĞUZ, Hilal | |
dc.contributor.author | Topuz, Erkan | |
dc.date.accessioned | 2021-03-03T20:52:04Z | |
dc.date.available | 2021-03-03T20:52:04Z | |
dc.identifier.citation | Çamlıca H., OĞUZ H., Disci R., Topuz E., Yasasever V., "Leptin and BCL-2 in addition to CA 12-5: Is it a sensitive and accurate way of diagnosis?", 31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.65 | |
dc.identifier.other | av_5c365383-ed2c-4270-acba-0e19becffee7 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/64674 | |
dc.language.iso | eng | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.title | Leptin and BCL-2 in addition to CA 12-5: Is it a sensitive and accurate way of diagnosis? | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 17 | |
dc.contributor.firstauthorID | 7455 | |